21-46161509-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001142854.2(SPATC1L):​c.893G>A​(p.Ser298Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0926 in 1,607,716 control chromosomes in the GnomAD database, including 7,828 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S298G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.10 ( 970 hom., cov: 31)
Exomes 𝑓: 0.091 ( 6858 hom. )

Consequence

SPATC1L
NM_001142854.2 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.10

Publications

10 publications found
Variant links:
Genes affected
SPATC1L (HGNC:1298): (spermatogenesis and centriole associated 1 like) Enables identical protein binding activity. Predicted to act upstream of or within several processes, including actin polymerization or depolymerization; positive regulation of cAMP-dependent protein kinase activity; and positive regulation of protein kinase A signaling. Predicted to be located in sperm connecting piece. Predicted to be active in centrosome. [provided by Alliance of Genome Resources, Apr 2022]
SPATC1L Gene-Disease associations (from GenCC):
  • hearing loss disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0012110174).
BP6
Variant 21-46161509-C-T is Benign according to our data. Variant chr21-46161509-C-T is described in ClinVar as Benign. ClinVar VariationId is 403468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.139 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPATC1LNM_001142854.2 linkc.893G>A p.Ser298Asn missense_variant Exon 5 of 5 ENST00000291672.6 NP_001136326.1
SPATC1LNM_032261.5 linkc.431G>A p.Ser144Asn missense_variant Exon 4 of 4 NP_115637.3
SPATC1LXM_005261188.6 linkc.893G>A p.Ser298Asn missense_variant Exon 5 of 5 XP_005261245.1 Q9H0A9-1
SPATC1LXM_011529756.3 linkc.551G>A p.Ser184Asn missense_variant Exon 3 of 3 XP_011528058.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPATC1LENST00000291672.6 linkc.893G>A p.Ser298Asn missense_variant Exon 5 of 5 2 NM_001142854.2 ENSP00000291672.5 Q9H0A9-1
SPATC1LENST00000330205.10 linkc.431G>A p.Ser144Asn missense_variant Exon 4 of 4 1 ENSP00000333869.6 Q9H0A9-2

Frequencies

GnomAD3 genomes
AF:
0.105
AC:
15879
AN:
151942
Hom.:
962
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.141
Gnomad AMI
AF:
0.138
Gnomad AMR
AF:
0.0877
Gnomad ASJ
AF:
0.0988
Gnomad EAS
AF:
0.0176
Gnomad SAS
AF:
0.120
Gnomad FIN
AF:
0.101
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0916
Gnomad OTH
AF:
0.111
GnomAD2 exomes
AF:
0.0891
AC:
21199
AN:
238008
AF XY:
0.0913
show subpopulations
Gnomad AFR exome
AF:
0.146
Gnomad AMR exome
AF:
0.0497
Gnomad ASJ exome
AF:
0.0991
Gnomad EAS exome
AF:
0.0191
Gnomad FIN exome
AF:
0.0963
Gnomad NFE exome
AF:
0.0952
Gnomad OTH exome
AF:
0.0878
GnomAD4 exome
AF:
0.0914
AC:
132979
AN:
1455656
Hom.:
6858
Cov.:
33
AF XY:
0.0920
AC XY:
66568
AN XY:
723542
show subpopulations
African (AFR)
AF:
0.142
AC:
4739
AN:
33376
American (AMR)
AF:
0.0527
AC:
2337
AN:
44384
Ashkenazi Jewish (ASJ)
AF:
0.0966
AC:
2512
AN:
26006
East Asian (EAS)
AF:
0.0146
AC:
578
AN:
39534
South Asian (SAS)
AF:
0.117
AC:
10095
AN:
85922
European-Finnish (FIN)
AF:
0.0965
AC:
4970
AN:
51518
Middle Eastern (MID)
AF:
0.0824
AC:
474
AN:
5750
European-Non Finnish (NFE)
AF:
0.0918
AC:
101794
AN:
1109100
Other (OTH)
AF:
0.0912
AC:
5480
AN:
60066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
7501
15002
22504
30005
37506
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3730
7460
11190
14920
18650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.105
AC:
15928
AN:
152060
Hom.:
970
Cov.:
31
AF XY:
0.105
AC XY:
7807
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.142
AC:
5894
AN:
41494
American (AMR)
AF:
0.0875
AC:
1339
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0988
AC:
343
AN:
3472
East Asian (EAS)
AF:
0.0175
AC:
90
AN:
5156
South Asian (SAS)
AF:
0.119
AC:
575
AN:
4832
European-Finnish (FIN)
AF:
0.101
AC:
1066
AN:
10580
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.0916
AC:
6224
AN:
67922
Other (OTH)
AF:
0.116
AC:
244
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
728
1455
2183
2910
3638
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0961
Hom.:
1106
Bravo
AF:
0.103
TwinsUK
AF:
0.0963
AC:
357
ALSPAC
AF:
0.0913
AC:
352
ESP6500AA
AF:
0.136
AC:
597
ESP6500EA
AF:
0.0943
AC:
809
ExAC
AF:
0.0918
AC:
11030
Asia WGS
AF:
0.104
AC:
359
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 19, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30177775) -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
21
DANN
Benign
0.93
DEOGEN2
Benign
0.0054
.;T
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.25
FATHMM_MKL
Benign
0.42
N
MetaRNN
Benign
0.0012
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.0
.;N
PhyloP100
1.1
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-0.26
N;N
REVEL
Benign
0.11
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
.;B
Vest4
0.070
MPC
0.16
ClinPred
0.0090
T
GERP RS
3.3
Varity_R
0.059
gMVP
0.29
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs14378; hg19: chr21-47581423; COSMIC: COSV52432428; API